Surrogate Endpoints for Efficacy in Clinical Research: Working Definitions and Validation

AACR Education book
doi 10.1158/aacr.edb-08-8214
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Prm1 - Validation of Alternative “Surrogate” Clinical Endpoints in Advanced Melanoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria

PLoS ONE
Multidisciplinary
2017English

Statistical Evaluation of Surrogate Endpoints in Clinical Studies

2014English

A Perspective on Surrogate Endpoints in Controlled Clinical Trials

Statistical Methods in Medical Research
Health Information ManagementEpidemiologyStatisticsProbability
2004English

Abstracts of the NIH-FDA Conference “Biomarkers and Surrogate Endpoints: Advancing Clinical Research and Applications”

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
1998English

Methodologic Issues in the Validation of Putative Biomarkers and Surrogate Endpoints in Treatment Evaluation for Systemic Lupus Erythematosus

Endocrine, Metabolic and Immune Disorders - Drug Targets
EndocrinologyAllergyImmunologyMetabolismDiabetes
2009English

Definitions of Anaesthetic Technique and the Implications for Clinical Research

Anaesthesia
AnesthesiologyPain Medicine
2017English

Surrogate and Intermediate Endpoints in Randomized Trials: What's the Goal?

Clinical Cancer Research
Cancer ResearchOncology
2018English

A Causal Framework for Surrogate Endpoints With Semi-Competing Risks Data

Statistics and Probability Letters
UncertaintyStatisticsProbability
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy